Adj. Docetaxel for Int. or High Risk Prostate Cancer After Rad: ASCO 2018 GU Highlights
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
Dr. Daniel Goldstein summarizes findings of a trial presented at ASCO 2018 by Dr. Kellolumpu-Lehtinen, ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
